Jun 3, 2026 06:50AM
Jun 3, 2026 06:38AM
Jun 3, 2026 05:28AM
Jun 3, 2026 04:33AM
Jun 2, 2026 09:21AM
Jun 2, 2026 08:51AM
Jun 2, 2026 08:11AM Celcuity reports positive Phase 3 trial results for gedatolisib in breast cancer
May 28, 2026 05:56AM
May 18, 2026 07:21AM
May 18, 2026 07:05AM
May 15, 2026 09:20AM
May 14, 2026 04:02PM
May 4, 2026 02:09PM
May 4, 2026 10:13AM Increasing unusual option volume: TPG XRX FXY CGNX MRAM CRNC CELC SIMO
May 4, 2026 10:01AM
May 4, 2026 07:24AM
May 4, 2026 07:21AM
May 4, 2026 06:59AM
May 4, 2026 06:14AM
Apr 27, 2026 01:58AM
Mar 27, 2026 06:47AM H.C. Wainwright Reiterates Neutral Rating on Celcuity Inc (CELC)
Mar 26, 2026 10:58AM
Mar 26, 2026 07:13AM
Mar 25, 2026 04:01PM
Mar 12, 2026 09:58AM
Mar 10, 2026 07:08AM
Mar 2, 2026 02:39PM
Feb 4, 2026 09:58AM Wolfe Research: 'We'd be buyers of CELC on any weakness related to the external catalyst'
Jan 20, 2026 07:30AM
Dec 23, 2025 05:30PM
Dec 17, 2025 04:02AM
Dec 12, 2025 05:22AM
Dec 1, 2025 05:10PM
Nov 25, 2025 11:15AM
Nov 18, 2025 11:50AM Increasing unusual call option volume: EQG CELC BBD FE CWAN
Nov 17, 2025 04:11PM
Nov 17, 2025 06:23AM
Nov 13, 2025 04:45AM
Nov 12, 2025 04:13PM
Oct 30, 2025 10:41AM
Sep 22, 2025 02:23AM
Sep 9, 2025 04:01PM Celcuity increases term loan facility to $500 million
Aug 18, 2025 06:47AM
Aug 15, 2025 11:47AM
Aug 15, 2025 07:08AM
Aug 15, 2025 05:08AM
Aug 14, 2025 04:02PM
Jul 29, 2025 06:41AM
Jul 14, 2025 07:06AM Celcuity receives patent extending gedatolisib exclusivity to 2042
Jul 1, 2025 05:18AM

401,681 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All